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Objective: Oxandrolone, administered to severely burned children over the first year
postburn, produces increased lean body mass by 6 months; however, an increase in to-
tal body bone mineral requires 12 months. Consequently, this bone mineral response
may be due to increased muscle mass. Alternatively, oxandrolone may act directly on
bone. The current study seeks to determine whether oxandrolone can transactivate the
androgen receptor in osteoblasts. Methods: Collagen, alkaline phosphatase, osteocal-
cin, osteoprotegerin, and androgen receptor abundance were determined by qRT-PCR,
confocal laser scanning microscopy, or immunoquantitative assay. To determine the ef-
fect of oxandrolone on gene expression in differentiated cells, osteocytic cultures were
grownt oconfluence in differentiation medium and then treated 24 hours or 5 days
with 15 µg/mL oxandrolone. Results: Increased nuclear fluorescence of the androgen
receptor and increased cellular type I collagen were observed with oxandrolone at 15
and 30 µg/mL but not at lower doses. Alkaline phosphatase (7%–20%) and osteocalcin
(13%–18%) increases were modest but significant. Short-term treatment produced no
significant effects, but at 5 days androgen receptor levels were increased while collagen
levels were significantly decreased, with little effect on alkaline phosphatase, osteocal-
cin, or osteoprotegerin. Conclusions: These data suggest oxandrolone can stimulate
production of osteoblast differentiation markers in proliferating osteoblastic cells, most
likely through the androgen receptor; however, with longer treatment in mature cells,
oxandrolonedecreasescollagenexpression.Thusitispossiblethatoxandrolonegivento
burned children acts directly on immature osteoblasts to stimulate collagen production,
but also may have positive effects to increase bone mineral through other mechanisms.
Long-term use of the orally administered anabolic agent oxandrolone has been shown
to increase both lean body mass and bone mineral content in severely burned children when
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given over the first year postburn.1 Oxandrolone and recombinant human growth hormone2
wereshowntobeeffectiveinrecoveringbonethatwouldordinarilybelostfollowingtheburn
injury, resulting in markedly reduced bone formation3 hypocellularity at the mineralization
front of bone3,4 and decreased marrow stromal cell differentiation into osteoblasts.4
Increased endogenous glucocorticoid production is likely responsible for the acute
bone loss observed in severely burned patients.3,4 Notably, with both oxandrolone and re-
combinant human growth hormone, an increase in lean body mass precedes an increase
in bone mineral content by 3 to 6 months.1,2 Thus it is not clear whether these anabolic
agents increase bone mineral content secondary to increased muscle mass and hence in-
creased skeletal loading, or whether they act directly on osteoblastic cells. Oxandrolone is
an anabolic steroid with the ability to transactivate the androgen receptor (AR), which may
be one mechanism underlying the anabolic response to therapy. The aim of our study is to
determine whether oxandrolone can increase osteoblastic production of type I collagen and
whether this action is mediated by AR signaling.
MATERIALS AND METHODS
Human osteoblast cell cultures
Freshlydiscardedhumancancellousboneswereobtainedfromhealthyyoungpatientsunder-
going osteotomy. The bone fragments were washed with serum-free α–minimum essential
medium (α-MEM, Flow Laboratories, McLean, VA). Then, the fragments were digested
in the medium with 1 mg/mL collagenase for 2 hours at 37◦C. The enzymatic reaction
was stopped by adding an equal volume of α-MEM with 10% fetal bovine serum (FBS).
The supernatant containing the released cells was recovered. Washing and recovering were
repeated 3 times. The cells were transferred to a centrifuge tube and centrifuge 10 minutes
at100×g toharvestthecells.Thecellpelletwasresuspendedin5mLoffreshmedium.The
singlecellsuspensionwasculturedinα-MEMcontainingantibiotics[penicillin(100U/mL),
streptomycin sulphate (100 µg/mL)] and 10% FBS in a humidified incubator at 37◦C under
an atmosphere of 5% CO2 and 95% air. After confluence, adherent cells were collected by
trypsinizing with 0.025% trypsin-EDTA and resuspended in α-MEM. Only passages 4 to
8w ere used in this study. Medium was changed every other day.4
Osteocytic cell culture
Osteoblasts in vitro progress through several developmental stages that correlate with os-
teoblast development in vivo: from committed preosteoblasts to mature, differentiated os-
teoblasts,andfinallytoosteocyte-likecellsembeddedinmineralizedextracellularmatrix.5–7
To characterize the effects of oxandrolone in osteocytic cells, human osteoblast cells were
cultured in α-MEM with 5% fetal bovine serum containing antibiotics for 10 days until
confluence, then switched to BGJb medium containing 50 µg/mL ascorbic acid and 3 mM
β-glycerol phosphate.7 Cultures were maintained in differentiation medium for 7 days for
mature osteoblast/osteocyte development,7 then treated with oxandrolone for time course
and dose-response analysis. These highly confluent osteocytic cultures were treated in 5%
charcoal-stripped serum with either 15 µg/mL of oxandrolone for 24 hours or 5 days, or
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with increasing concentrations of oxandrolone (0, 1, 5, 10, and 15 µg/mL) for 5 days. Total
RNA was isolated for gene expression analysis as described below.
Immunohistochemistry for collagen type I and AR
Immunohistochemical staining was carried out for both the AR8,9 and type I collagen. Hu-
man osteoblastic cells were trypsinized, seeded on slide chambers (Lab-Tek, Nalge Nunc
International, Rochester, NY) at a concentration of 1 × 105cells/mL and cultured for 3 days
until they achieved 60% to 70% confluence. Oxandrolone was used to stimulate the cells
at the concentration of 1, 5, 10, 15, and 30 µg/mL for 24 hours. Stock solution containing
2.5 mg diluted in 2 mL of DMSO was prepared and subsequently diluted in culture media,
while control nonstimulated cells received the same solution without oxandrolone. There-
after, the medium was discarded, the cells were washed with phosphate buffered saline
(PBS), and fixed in −20◦C methanol/acetone (50:50) for 20 minutes and permeabilized
with 0.5% Triton X-100 (Sigma, St Louis, MO). The polyclonal antibody used for collagen
Iw as applied overnight at the dilution of 1:200 (Research Diagnostics Inc, Flanders, NJ).
The polyclonal antibody for AR (Neomarkers, Fremont, CA) was used at the dilution of
1:30. The next day, FITC-conjugated goat anti-rabbit IgG was used as secondary antibody
(Neomarkers)andcellnucleiwerestainedwith4,6-diamidino-2-phenylindole(DAPI)(Vec-
tor Mounting Medium, Burlingame, CA). Images were captured using the laser confocal
scanning microscope (Zeiss LSM 510, Jena, Germany) with a 63× objective. Optical sec-
tions were obtained from the cells by capturing single images of central cell focal planes.
Three microscopic fields were captured for the control group of each cell line and the same
was done for cells treated with oxandrolone. To proceed to an analysis of AR immunohis-
tochemistry, the intensity of fluorescence was measured in the nuclei (AR) in 2 cells per 3
fields,usingImageToolsoftware(UniversityofTexasHealthScienceCenter,SanAntonio).
Assay of alkaline phosphatase
Humanosteoblasticcellswereculturedinα-MEMcontainingantibioticsand10%FBS.The
cellswerechallengedwithincreasingconcnetrationsofoxandrolone(0,1,510,15µg/mL).
After24hoursoftreatment,thelevelsofalkalinephosphataseactivityweredeterminedusing
a commercial kit (Pierce Biotechnology, Inc, Rockford, IL). The cells were washed with
cold PBS and subjected to 3 freeze-thaw cycles. These samples were assayed for enzymatic
activity with p-nitrophenyl phosphate as a substrate. Sample absorbance was measured at
400 nm with microplate reader. Results were expressed in ALP (OD)/protein (OD).
Immunoquantitative assay for collagen type I and osteocalcin
To perform the immunoquantitative assay for type I collagen4 and osteocalcin, human
osteoblastic cells were subcultured on 96-well plates until they achieved 70% confluence.
Oxandrolonewasusedtostimulatethecellsattheconcentrationof0,1,10,15,and30µg/mL
for 24 hours. Cells were harvested and washed with cold PBS, fixed in methanol for 10
minutes at −20◦C and washed with PBS. They were then preincubated with primary anti-
body for type I collagen and osteocalcin (Santa Cruz Biotechnology Inc, CA), respectively,
overnight at 4◦C, followed by secondary biotinylated IgG for 30 minutes at room temper-
ature. After washing with PBS, cells were exposed to p-nitrophenyl phosphate containing
levamisole to inhibit the generation of p-nitrophenol by endogenous alkaline phosphatase
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for 8 minutes. Sample absorbance was measured at 400 nm with an ELISA reader. The
values (OD) were normalized with protein concentration (OD).
Real-time quantitative reverse transcription–polymerase chain reaction (qRT-PCR)
on cultured human osteocytic cells
Total RNA was isolated from osteocytic cultures and gene expression characterized by
qRT-PCR analysis using human primers from Qiagen (Valencia, CA) specific for AR and
the osteoblast marker proteins alkaline phosphatase, type I collagen, osteocalcin, and os-
teoprotegerin. The qRT-PCR analysis was performed with the iCycler IQ Real Time PCR
detection system (Bio-Rad Laboratories, Inc, Hercules, CA) using a one-step QuantiTect
SYBR Green RT-PCR kit (Qiagen) on DNase-treated total RNA. Relative expression of the
RT-PCRproductwasdeterminedusingthecomparative  Ct methodafternormalizingex-
pression with fluorescence to the specific RNA-binding dye RiboGreen (Molecular Probes,
Eugene, OR) as previously described.10 Real-time qRT-PCR efficiency was determined for
each primer set using a fivefold dilution series of total RNA and did not differ significantly
from 100%. Individual reaction kinetics were also analyzed to ensure each real-time RT-
PCR did not differ significantly from 100% efficiency. Following PCR, specificity of the
PCR reaction was confirmed with inverse derivative melt curve analysis. Data is presented
as mean ± SEM.
Statistical analyses
Data are reported as mean ± SEM. The statistical significance of intergroup differences
was tested using the Student t test when the variances were equal. P less than .05 was
considered significant.
RESULTS
Oxandrolone treatment in proliferating human osteoblastic cells
Proliferating cultures of normal human osteoblastic cells were treated for 24 hours with
30 µg/mL oxandrolone or vehicle to determine the acute response to oxandrolone treat-
ment. Although the affinity for oxandrolone for AR is approximately 100-fold lower than
testosterone, oxandrolone treatment still results in AR transactivation.11 To characterize the
ability of oxandrolone to stimulate translocation of the AR to the nucleus, confocal laser
scanning microscopy was employed. When control cultures were stained for AR, diffuse
cytoplasm staining but only weak nuclear staining were observed on osteoblasts nonstimu-
latedwithoxandrolone(Fig1a).Afterstimulationwithoxandrolone,increasedfluorescence
of AR in the nuclei was seen (Fig 1b), suggesting transactivation by oxandrolone at these
concentrations.
We next assessed the effect of oxandrolone treatment on type I collagen, the major
constituent of the bone matrix. Immunohistochemistry for collagen type I on cultured os-
teoblastcellsdemonstratedanincreaseincollagenthatwasdosedependent.Whencompared
tocontrolgroup(Fig1c),asignificantincreasedintensityoffluorescencewasseenforcells
stimulated with oxandrolone. This was observed when the concentration of oxandrolone
was 15 µg/mL (Fig 1f) and 30 µg/mL (Fig 1d).
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Figure 1. Confocal scanning laser microscopic analysis of human osteoblastic cells after oxan-
drolone treatment. (a) Confocal scanning laser microscopy depicting AR nuclear fluorescence of
human osteoblastic cells not stimulated with oxandrolone, (b) confocal scanning laser microscopy
depicting the increased AR nuclear fluorescence of human osteoblastic cells stimulated with oxan-
drolone 30 µg/mL, (c) confocal scanning laser microscopy depicting cytoplasmic fluorescence of
type I collagen in human osteoblastic cells not stimulated with oxandrolone, (d) confocal scan-
ning laser microscopy depicting increased cytoplasmic fluorescence of type I collagen in human
osteoblastic cells stimulated with oxandrolone 30 µg/mL, (e) internal negative control for primary
antibodies of AR and type I collagen, (f) confocal scanning laser microscopy depicting increased
cytoplasmicfluorescenceoftypeIcollageninhumanosteoblasticcellsstimulatedwithoxandrolone
15 µg/mL. Compare to Figures 1c and 1d.
To determinetheeffectofoxandroloneonadditionalmarkersofosteoblastactivity,os-
teoblastic cultures were treated with or without oxandrolone. Alkaline phosphatase activity
was determined in cells treated with oxandrolone for 24 hours (Fig 2), and there was an in-
crease (7%–20%) in activity in a dose-dependent manner. The differences were statistically
significant(P<.05)butthechangeswereminorcomparedtothecontrolgroup.Wealsoper-
formed immunoquantitative assays for type I collagen and osteocalcin on osteoblastic cells.
Inculturestreatedwithoxandrolone(10or15µg/mL),collagenwasincreased21%to35%
(Fig 3; P< .05). There were no differences in the groups treated with low concentrations
of oxandrolone (1 or 5 µg/mL) compared to control group. Thus, after multiple repetitions
of the experiment, the data confirmed the results observed using immunofluorescence.
We next assessed the levels of osteocalcin, an important biochemical indicator of bone
turnover.12 Cellstreatedwithoxandroloneof10,15,and30µg/mLproducedagreaterlevel
ofosteocalcin(11%–18%)comparedtothecontrolgroup.Thedifferenceswerestatistically
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Figure 2. Stimulation of alkaline phosphatase activity by
oxandrolone in proliferating human osteoblastic cultures.
Proliferating cultures were treated acutely for 24 hours with
0, 1, 5, 10, and 15 µg/mL oxandrolone. Data are expressed
as mean ± SEM of 6 determinations.
Figure 3. Increased osteocalcin levels after oxandrolone treat-
ment. Human osteoblastic cultures were exposed to oxandrolone
(0, 1, 5, 10, and 15 µg/mL) for 24 hours. Data are expressed as
mean ± SEM of 6 determinations.
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Figure 4. Enhanced type I collagen secretion after oxan-
drolone exposure. Proliferating cultures were treated with 0,
1, 5, 10, and 15 µg/mL oxandrolone for 24 hours. Data are
expressed as mean ± SEM of 6 determinations.
significant (Fig 4; P< 0.05) but again the increase was small. Thus, the production of
osteocalcin mirrored the pattern of alkaline phosphatase activity.
AR concentrations increase as osteoblasts differentiate, reaching their highest lev-
els in osteocytic cultures.13 Furthermore, the most abundant cell in bone is the osteocytic
cell. We therefore determined the effect of oxandrolone treatment on gene expression in
mature osteocytic cultures. Normal human osteoblasts were cultured for 10 days, then
switched to differentiation medium containing ascorbic acid and β-glycerol phosphate.
After 7 days, osteocytic cells were treated with 15 µg/mL oxandrolone. Total RNA was
isolated after 24 hours or 5 days treatment, and gene expression characterized by qRT-
PCR analysis using human primers specific for AR, type I collagen, alkaline phosphatase,
osteocalcin, and osteoprotegerin (Fig 5). Although there was little effect of oxandrolone
after 24 hours of treatment in osteocytic cells on type I collagen, alkaline phosphatase,
osteocalcin, or osteoprotegerin mRNA abundance, a nonsignificant increase in AR mRNA
was noted. This is consistent with other reports documenting an increase in AR after an-
drogen treatment in osteoblasts.14 After stimulation with oxandrolone for 5 days, a signif-
icant decrease in expression of type I collagen was seen (P< 0.01). Thus, longer treat-
ments with oxandrolone in osteocytic cultures reduced collagen expression. These data are
consistent with dose-response studies performed after 5 days of treatment with increas-
ing concentrations of oxandrolone (Fig 6), where AR mRNA is modestly increased but
collagen levels are significantly decreased in a dose-dependent fashion with oxandrolone
treatment.
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Figure 5. Consequence of oxandrolone treatment on gene expression in normal human os-
teocytes: time course analysis. Normal human osteoblastic cells were cultured for 10 days
to confluence, then switched to differentiation medium containing ascorbic acid and
β-glycerol phosphate. After 7 days, osteocytic cells were treated with 15 µg/mL oxan-
drolone. Total RNA was isolated after 24 hours or 5 days treatment, and gene expression
characterized by qRT-PCR analysis using human primers specific for AR, type I collagen
(col), alkaline phosphatase (ALP), and osteocalcin (OC) and osteoprotegerin (OPG). n = 3
to 4. ∗∗P< .01.
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Figure 6. Consequence of oxandrolone treatment on gene expression in normal human osteocytes:
dose-response analysis. Normal human osteoblastic cells were cultured as described in Figure 5.
Osteocytic cultures were treated for 5 days with 0, 1, 5, 10, and 15 µg/mL oxandrolone. Total RNA
was isolated and gene expression characterized by qRT-PCR analysis using human primers specific
for AR, type I collagen (col), alkaline phosphatase (ALP), osteocalcin (OC) and osteoprotegerin
(OPG). n = 2t o4 .∗P< .05; ∗∗P< .01.
DISCUSSION
In this study we have shown that stimulation of cultured human osteoblasts by oxandrolone
results in immunofluorescent detection of AR in the nucleus and increased osteomarkers in
these osteoblasts. These data suggest that oxandrolone directly targets human osteoblasts
by means of the AR, resulting in increased expression of osteoblast differentiation markers
after short-term treatment. Therefore, oxandrolone may act directly on the osteoblast in
addition to effects that result in increasing skeletal loading.
61JOURNAL OF BURNS AND WOUNDS VOLUME 6
Immunohistochemistry and confocal laser scanning microscopy (CLSM) were used to
evaluate the expression of AR and type I collagen in osteoblasts, with several advantages
over regular fluorescence microscopy.15,16 While in conventional wide-field fluorescence
microscopy the emitted light coming from regions above and below the focal plane is
collected by the objective lens and contributes to an out-of-focus blur in the final image, in
theCLSMadiaphragmrejectstheout-of-focusinformation.15,16 Therefore,tissuethickness
doesnotinterferewiththeresultingfluorescence.TheincreasedexpressionoftypeIcollagen
by osteoblasts was also determined by immunoassay confirming the results observed with
immunohistochemistry.
The AR is a steroid receptor that generally mediates biologic responses to androgens.
The increased expression of AR in the present study is consistent with that documented in
the literature.14 In bone tissue the AR is expressed in a variety of cell types, but its specific
role in the maintenance of skeletal homeostasis remains controversial.17 In an experimental
study, androgen deficiency was shown to result in a substantial loss of cancellous bone in
the axial and appendicular skeleton of aged male rats and that this osteopenia is associated
with a sustained increase in bone turnover.18 Consistent with this, the bone phenotype that
develops in a global AR null (ARKO) male mouse model is a high-turnover osteopenia,
with reduced trabecular bone volume, and a significant stimulatory effect on osteoclast
function.19,20
Alkalinephosphataseiswellrecognizedasamarkerthatreflectsosteoblasticactivity.21
Kasperketalreportedthatandrogensincreasethealkalinephosphataseactivityinosteoblast
culture.22–24 However, there are also reports of androgens either inhibiting25 or having
no effect on alkaline phosphatase activity,26,27 which may reflect both the complexity of
osteoblastic differentiation and the various model systems employed. In a clinical study,
Murphyetal1haveshownthatoxandroloneadministrationincreaseslevelsofserumalkaline
phosphatase in treated patients by 6 months versus controls. In the present study, the cells
treated with oxandrolone produced a greater level of alkaline phosphatase. The elevated
activity of this cellular enzyme suggests an early increase in the osteoblast differentiation
process.
Osteocalcin appears to be a bone-specific gla-containing protein, accounting for 10%
to 20% of the noncollagenous protein in bone. While the in vivo function of osteocalcin
remains unclear, its affinity for bone mineral constituents implies a role in bone formation.
Hence it has been shown that osteocalcin is a biochemical indicator of bone turnover.12
In our study, proliferating cells treated for 24 hours with oxandrolone produced small but
statistically significant increases in osteocalcin production compared to control group.
To testtheeffectofoxandroloneonosteocyte-likecellsdifferentiatedfromosteoblasts
atthemolecularlevel,thehumanosteoblasticcellswereculturedinadifferentiationmedium
and then exposed to oxandrolone. The results showed that short-term treatment produced
little effect on type I collagen, alkaline phosphatase, osteocalcin, osteoprotegerin, or AR
mRNA. Long-term treatment decreased type I collagen expression, consistent with de-
creased collagen expression observed by Wiren et al16 in AR-transgenic mice with targeted
AR overexpression in the osteoblast lineage.16 The results described here are consistent
with observations reported in vivo with male AR-transgenic mice, where calvarial thick-
ening is observed and cortical formation is altered with surface periosteal expansion but
inhibition of inner endosteal deposition, consistent with the known effects of androgen to
stimulate periosteal apposition. The dramatic inhibition at the endosteal envelope may be
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responsible for a modest decrease in cortical bone area and reductions in biomechanical
propertiesobserved.16 Thus,takingalldatatogether,ourresultssuggestthatosteoblastcells
are targeted by androgens to transactivate AR in bone.
Murphyetal1 haverecentlyshownthatoxandroloneadministrationincreasesleanbody
mass 3 to 6 months before an increase in bone mineral content is observed. On the other
hand, we have found an increase in collagen production when high doses of oxandrolone
were used to stimulate osteoblasts. The applicability of our findings in this study to the in
vivo effects of oxandrolone in burned children1 is not clear. While an in vitro environment
may not adequately reproduce the in vivo situation, many potential variables are eliminated
during in vitro studies, and it is possible to investigate a specific effect of a drug on cells.
The time frame of in vivo and in vitro settings is plainly different, and the concentration of
oxandrolone used to stimulate cells in the in vitro setting is probably higher than the one
used in the clinical trial.1 Therefore, the results may not be strictly comparable. Although
this study demonstrates that oxandrolone is capable of affecting the osteoblast AR and
stimulating type I collagen synthesis, regulatory mechanisms that are present only in a
complex in vivo situation may account for increased collagen turnover or degradation after
synthesis.
Moreover, the delay in the increase of total body bone mineral content reported in
the clinical study by Murphy et al1 may be explained in part by the acute inhibition of
bone formation and osteoblast differentiation after a severe burn as previously reported.3,4
Thus there may have been a lack of osteoblasts, and therefore osteoblast AR, to mediate a
response to oxandrolone.
In conclusion, the use of high-dose oxandrolone results in increased nuclear fluores-
cence of the osteoblast AR, increased osteoblast differentiation markers in cultured os-
teoblasts and decreased bone marker in cultured osteocyte-like cells in vitro. Oxandrolone
may have the ability to directly stimulate bone collagen synthesis, over and above its effect
on skeletal loading effected through an increase in lean body mass following long-term
treatment. However, longer exposure may no longer be directly anabolic in mature bone
cells.Thisobservationmayhelptoexplainthevariabilityandconfusionregardingandrogen
actions on the skeleton.
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